...
首页> 外文期刊>Transplantation: Official Journal of the Transplantation Society >Acute renal failure following kidney transplantation associated with myoglobinuria in patients treated with rapamycin.
【24h】

Acute renal failure following kidney transplantation associated with myoglobinuria in patients treated with rapamycin.

机译:雷帕霉素治疗的患者肾移植后伴有肌红蛋白尿的急性肾功能衰竭。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: Since using an immunosuppression regimen that includes rapamycin, we have occasionally encountered renal transplant patients who develop unexpected severe acute renal dysfunction. Biopsies obtained in these recipients demonstrate acute tubular necrosis (ATN) occasionally associated with tubular casts giving the classic appearance of myoglobin casts. METHODS: We retrospectively reviewed all biopsies from consecutively transplanted kidneys engrafted between April 9, 2002 and June 29, 2004 to determine the incidence of ATN, ATN with intratubular casts, and casts with the classic myoglobin appearance. The clinical setting, treatment, and outcomes of those patients with classic myoglobin-appearing casts are reviewed. RESULTS: Histological ATN as the principal finding in at least one biopsy occurred in 10.5% (57/543) of patients. About half of these patients (30/57) had tubular casts present in at least one biopsy and in 14 of these the casts had a classic appearance of myoglobin casts. These myoglobin-appearing casts were only noted in patients receiving rapamycin. A review of 28 ATN biopsies from an earlier prerapamycin era did not demonstrate similar myoglobin-appearing casts. Immunostaining for myoglobin was positive in all 14 recipient biopsies. This was confirmed by western blot analyses in three of five patient biopsies tested. Three of three recipients tested had elevated serum creatine phosphokinase levels and detectable serum myoglobin. All 14 patients slowly resolved their acute renal dysfunction and no grafts were lost. CONCLUSION: We conclude that myoglobinuria with myoglobin cast formation can occur following rapamycin administration, and may be a causative factor in the development of unexpected severe acute renal dysfunction.
机译:背景:自从使用包括雷帕霉素的免疫抑制方案以来,我们偶尔会遇到肾移植患者,这些患者会发展出意想不到的严重急性肾功能不全。在这些接受者中获得的活检表明,急性肾小管坏死(ATN)有时与肾小管铸型有关,并表现出典型的肌红蛋白铸型外观。方法:我们回顾性分析了2002年4月9日至2004年6月29日之间连续移植的肾脏的所有活检组织,以确定ATN,管内铸型和经典肌红蛋白铸型的ATN的发生率。回顾了那些出现经典肌红蛋白铸型的患者的临床背景,治疗和预后。结果:组织学ATN作为至少一项活检的主要发现发生在10.5%(57/543)的患者中。这些患者中大约一半(30/57)至少在一次活检中有肾小管铸型,其中14个具有典型的肌红蛋白铸型外观。这些出现肌红蛋白的管型仅在接受雷帕霉素的患者中发现。对来自更早雷帕霉素时代的28例ATN活检的回顾未显示出类似的出现肌红蛋白的铸型。肌红蛋白的免疫染色在所有14位接受者活检中均为阳性。通过蛋白质印迹分析,在接受测试的五名患者活检物中有三名得到了证实。接受测试的三位接受者中有三位的血清肌酸磷酸激酶水平升高,并且血清肌红蛋白可检测。所有14例患者均能缓慢缓解其急性肾功能不全,并且没有丢失任何移植物。结论:我们得出结论,雷帕霉素给药后可发生肌红蛋白尿伴肌红蛋白铸型形成,并且可能是意料之外的严重急性肾功能不全发展的原因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号